More PRNewswire
View Older Stories View Newer Stories-
Renovus Capital Partners Announces Investment In Behavioral Framework
-
Ultra Clean to Participate in 26th Annual Needham Growth Conference
-
ENSEM Expands its Leadership Team with the Appointment of Jeff Kutok, M.D., Ph.D. as Chief Scientific Officer
-
Virtual Autism Clinic 'As You Are' Expands to All 50 States
-
Palisade Capital Management Certified By the Women's Business Enterprise National Counsel
-
Digital Brands Group Forecasts $27M to $30M in Revenue, $6M to $7M in Internal Free Cash Flow and $1.5M to $2.0M in EBITDA for 2024
-
Converge Technology Solutions Announces UK and Germany Operations Achieve IBM Platinum Partner Status
-
AMERICAN KENNEL CLUB'S PACK EXPANDS IN 2024
-
TC BioPharm Announces Additional Cost Reduction Steps to Improve Financial Standing and Streamline Efficiencies
-
TE Connectivity to report first quarter financial results on Jan. 24, 2024
-
Kinetic Group, Inc. Finalizes Acquisition of Binnops US Technologies Inc- An AI Company Providing Digital Transformation Solutions to Enterprises
-
Pennington Partners & Co. Announces Launch of Real Estate Investment Vertical
-
Yume Unveils a Platform Where Recovery Coaches Who've Conquered Their Addictions Guide Others to Sobriety
-
Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Avantor® to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
-
HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
-
Society Brands Acquires Akron, Ohio-Based Primal Life Organics to Further Expand Business and Spread "The Clean Beauty Movement"
-
Intensity Therapeutics Provides Business Update Reflecting Progress in Phase 3 Sarcoma Program
-
J.H. Whitney Data Services Unveils Geostrategic Risk Ratings for Public Companies
-
INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program
-
Houston Natural Resources Corp Updates Shareholders
-
New Published Data Demonstrates Correlation Between Itch Cytokine Interleukin-31 Reduction and Pruritis Improvement in Primary Biliary Cholangitis in Phase 3 Post-Hoc Analysis of CymaBay's Seladelpar
-
PEET'S COFFEE TURNS WINTER BLUES INTO GOLDEN HUES WITH COFFEE-FIRST SEASONAL MENU
-
Vasa Therapeutics Announces Closing of Seed Financing to Advance Novel Therapies for Diseases of Cardiovascular Aging
-
Sionna Therapeutics to Present Updates on Clinical Progress in Cystic Fibrosis at 42nd Annual J.P. Morgan Healthcare Conference
-
OPENLANE Launches Visual Boost AI™ to Pinpoint Vehicle Damage
-
Mill Creek Announces Start of Preleasing at Modera Garden Oaks
-
Massivit to Present Virtually at the 26th Annual Needham Growth Conference on Friday, January 19
-
Ace Global Business Acquisition Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
-
Alcyone Therapeutics Announces First Patient Implanted in PIERRE IDE Clinical Study of the ThecaFlex DRx™ System for Administration of SPINRAZA® (nusinersen)
-
Acurx to present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Living Legends of Aviation to Honor First-Ever Recipient of Prestigious "Dr. Sam B. Williams Technology Award"
-
WESTERN AIR APPOINTS FIRST WOMAN PRESIDENT & CEO, SHERREXCIA "REXY" ROLLE; APPOINTS REX ROLLE AS CHAIRMAN.
-
SonicWall Accelerates SASE Offerings; Acquires Proven Cloud Security Provider
-
BioMarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, at 10:30 am PT / 1:30 pm ET, in San Francisco, CA
-
A 2024 Cyclist Buyer's Guide to America's Best Bicycle Insurance
-
May Mobility CEO Edwin Olson to speak at CES® 2024
-
CRUSH YOUR NEW YEAR'S GOALS WITH QDOBA MEXICAN EATS® NEW POST-WORKOUT BOWLS
-
Fitness Influencers Dayana Perozo, Ron "Boss" Everline, Denise Austin and More Unite This Month to Help End Childhood Hunger by Joining 'Get Fit for No Kid Hungry'
-
CSL Behring Announces Availability of Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) 10g Prefilled Syringe
-
New Study Reports IceCure's ProSense® Boosts Immune Response Against Cancer: Enhances CD8+ T Cell Response
-
McCormick & Company to Report 2023 Fourth Quarter Financial Results on January 25, 2024
-
PTC Therapeutics to Participate at 42nd Annual J.P. Morgan Healthcare Conference
-
On Target Laboratories Names Scott Huennekens as Executive Chairperson of the Board
-
Cardionomic Announces Enrollment Completion in the STIM-ADHF and STOP-ADHF Pilot Studies
-
Valens Semiconductor Unveils a New Brand Identity that Places Its Cutting-Edge Chipsets Center Stage
-
Carbonaires and the Republic of North Macedonia forge pioneering partnership to build robust Voluntary Carbon Markets
-
ThunderSoft Selects C2A Security along with Amazon Web Services, Arm, Blackberry IVY, and others to create new Vehicle OS
-
Lights Up the Future: New Olight.com Debuts
-
Jerry State of the American Driver Report Declares 2024 the "Year of the Hybrid" as Heightened Car Buying Demand Signals Car Market Recovery
